George JACKOWSKI,Rachelle MACSWEENEY,Nisar Ahmad SHAIKH,Jason YANTHA,Valerie B. SCHINI-KERTH
申请号：
US14588818
公开号：
US20150119414A1
申请日:
2015.01.02
申请国别(地区):
US
年份:
2015
代理人:
摘要：
A composition and a method of treatment utilizing a combination of statins (or HMG-CoA reductase inhibitors), a class of drug used to lower cholesterol levels by inhibiting the enzyme HMG-CoA reductase, with mixtures of an omega-3 fatty acid formulation containing about 90% or more omega 3 fatty acids by weight including a combination of Eicosapentaenoic acid (EPA), Docosapentaenoic acid (DPA) and Docosahexaenoic acid (DHA) in a weight ratio of EPA:DHA of from 5.7 to 6.3, wherein the sum of the EPA, DHA and DPA represent about 82% by weight of the total formulation and about 92% of the total omega 3 fatty acid content of the composition are taught.
